Tower Research Capital (TRC)’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-6,714
| Closed | -$15.3K | – | 6068 |
|
|
2024
Q2 | $15.3K | Buy |
6,714
+2,610
| +64% | +$5.95K | ﹤0.01% | 3914 |
|
|
2024
Q1 | $17.7K | Sell |
4,104
-1,996
| -33% | -$8.62K | ﹤0.01% | 3102 |
|
|
2023
Q4 | $18.6K | Sell |
6,100
-1,995
| -25% | -$6.09K | ﹤0.01% | 3693 |
|
|
2023
Q3 | $11.7K | Sell |
8,095
-26,455
| -77% | -$38.1K | ﹤0.01% | 3966 |
|
|
2023
Q2 | $86K | Buy |
34,550
+26,127
| +310% | +$65.1K | ﹤0.01% | 2120 |
|
|
2023
Q1 | $23K | Buy |
8,423
+95
| +1% | +$259 | ﹤0.01% | 3307 |
|
|
2022
Q4 | $46K | Sell |
8,328
-9,076
| -52% | -$50.1K | ﹤0.01% | 2422 |
|
|
2022
Q3 | $217K | Buy |
17,404
+14,724
| +549% | +$184K | ﹤0.01% | 1851 |
|
|
2022
Q2 | $13K | Sell |
2,680
-9,904
| -79% | -$48K | ﹤0.01% | 4240 |
|
|
2022
Q1 | $95K | Sell |
12,584
-12,096
| -49% | -$91.3K | ﹤0.01% | 2242 |
|
|
2021
Q4 | $252K | Buy |
24,680
+12,565
| +104% | +$128K | ﹤0.01% | 1591 |
|
|
2021
Q3 | $163K | Sell |
12,115
-1,510
| -11% | -$20.3K | ﹤0.01% | 2000 |
|
|
2021
Q2 | $299K | Buy |
13,625
+11,961
| +719% | +$262K | 0.01% | 1609 |
|
|
2021
Q1 | $40K | Sell |
1,664
-8,676
| -84% | -$209K | ﹤0.01% | 3324 |
|
|
2020
Q4 | $186K | Buy |
10,340
+5,453
| +112% | +$98.1K | 0.01% | 1769 |
|
|
2020
Q3 | $57K | Buy |
4,887
+33
| +0.7% | +$385 | ﹤0.01% | 3486 |
|
|
2020
Q2 | $118K | Buy |
4,854
+2,774
| +133% | +$67.4K | ﹤0.01% | 2315 |
|
|
2020
Q1 | $23K | Buy |
+2,080
| New | +$23K | ﹤0.01% | 1651 |
|
|
2019
Q4 | – | Sell |
-170
| Closed | -$4K | – | 4538 |
|
|
2019
Q3 | $4K | Buy |
+170
| New | +$4K | ﹤0.01% | 3478 |
|
|
2018
Q4 | – | Sell |
-80
| Closed | -$4K | – | 4484 |
|
|
2018
Q3 | $4K | Buy |
+80
| New | +$4K | ﹤0.01% | 3234 |
|
|
2017
Q4 | – | Sell |
-1,156
| Closed | -$29K | – | 4220 |
|
|
2017
Q3 | $29K | Buy |
1,156
+607
| +111% | +$15.2K | ﹤0.01% | 2481 |
|
|
2017
Q2 | $9K | Buy |
+549
| New | +$9K | ﹤0.01% | 1680 |
|